A Study of the Safety and Efficacy of EBV Specific T-cell Lines
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
- Status
- TERMINATED
- Phase
- PHASE1
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy
- Status
- COMPLETED
- Phase
- N/A
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
- Status
- COMPLETED
- Phase
- N/A
Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL
- Status
- UNKNOWN
- Phase
- PHASE1
Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- N/A
A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1
Illness Management and Parental Adjustment to Cancer Treatment
- Status
- COMPLETED
- Phase
- NA
Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM)
- Status
- COMPLETED
- Phase
- N/A
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of the Angiogenesis by PET/CT in Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lonquek for Autologous Stem Cell Mobilization
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
FDG-PET/CT Imaging as Early Predictor of DP
- Status
- COMPLETED
- Phase
- N/A
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1